Showing results (431-440 of 686) with videos related to

Sort By:
Pageof 69
International Journal of Cancer|March 17, 2001
Pronounced antitumor efficacy of doxorubicin when given as the prodrug DOX-GA3 in combination with a monoclonal antibody beta-glucuronidase conjugateP H Houba, E Boven, I H van der Meulen-Muileman, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Tumor size and origin determine the antitumor activity of cisplatin or 5-fluorouracil and its modulation by leucovorin in murine colon carcinomasJ A Van Laar, Y M Rustum, C L Van der Wilt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2004
Reduced growth, increased vascular area, and reduced response to cisplatin in CD13-overexpressing human ovarian cancer xenograftsYvette van Hensbergen, Henk J Broxterman, Sareena Rana, et al.
British Journal of Cancer|March 4, 1998
Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancerA H Honkoop, P J van Diest, J S de Jong, et al.
Clinical Pharmacology and Therapeutics|February 1, 1986
Pharmacokinetics of free and total platinum species after rapid and prolonged infusions of cisplatinJ B Vermorken, W J van der Vijgh, I Klein, et al.
British Journal of Cancer|March 20, 2003
Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivityM de Bruin, T van Capel, K Van der Born, et al.
Hepato-Gastroenterology|June 18, 2002
Metastasectomy and active specific immunotherapy for a large single melanoma metastasisA Baars, J M G H van Riel, M A Cuesta, et al.
Anticancer Research|November 1, 1987
Morphometric study of myocardial changes during puromycin aminonucleoside induced nephropathy in ratsW J van der Vijgh, D Van Velzen, J S Van der Poort, et al.
Pageof 69